Portage Biotech has announced the completion of a private placement of $2.15 million from two of its directors, with the proceeds intended for working capital and general corporate purposes for the company and its subsidiaries. The 524,390 ordinary shares were sold at $4.10 per share.
Company Information
Company
Portage Biotech
Location
Clarence Thomas Building, PO Box 4649
Road Town, Virgin Islands, British
About
Portage Biotech is clinical stage biopharmaceutical company driving the development of first-in-class immuno-oncology therapies to help more patients achieve durable treatment responses and a better quality of life. The Company is using its strong industry network and diverse drug platforms to identify novel assets and asset combinations.
